Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

HHS announced Thursday (May 19) that it is committing up to $300 million over 10 years for researching and developing therapeutics, preventatives and diagnostics to combat antimicrobial resistant infections.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.